|
||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BRIEF DEFINITIVE REPORT |
CORRESPONDENCE Markus F. Neurath: neurath{at}1-med.klinik.uni-mainz.de
|
|
|---|
Recently, IL-27 has been identified as a new bioactive member of the IL-12 cytokine family (3). It consists of an IL-12 p40related polypeptide, denoted EBV-induced gene 3 (EBI3), and a novel p28 subunit with some similarities to IL-12 p35 and IL-23 p19, respectively (3, 4). The IL-27 heterodimer mediates its biological function via binding to a specific receptor on target cells consisting of the orphan receptor WSX-1/TCCR and the widely expressed gp130 protein (5). Over the last several years, IL-27 has emerged as a pivotal cytokine in the adaptive immune system by controlling T celldependent immune responses. Hereby, IL-27 activates STAT1 and STAT3 in naive CD4 T cells and NK cells. While STAT1 phosphorylation is required for IL-27mediated activation of the Th1 master transcription factor T-bet (6), STAT3 is considered to be important for IL-27induced T cell proliferation (7).
DCs and macrophages have been identified as rapid producers of IL-27 subunits after Toll-like receptor (TLR) ligation (8), suggesting that IL-27 may act very early in Th1-mediated immunity. However, recent studies demonstrated that the biological function of IL-27/WSX-1 signaling is more complex, as it is also critically involved in the negative control of both Th1 and Th2 inflammatory responses (911). Finally, mice deficient for the EBI3 subunit of IL-27 showed reduced iNK T cell numbers and cytokine production, suggesting that EBI3 controls iNK T cell activity (12).
Because WSX-1 is highly expressed on naive T cells, IL-27related research primarily concentrated on the biology of T cells; however, WSX-1 and gp130 are also expressed on B cells, DCs, macrophages, and mast cells, suggesting that IL-27 function is not restricted to T cells. In fact, stimulation of human mast cells and blood monocytes with rIL-27 led to the activation of STAT transcription factors and production of proinflammatory cytokines (5). However, IL-27 signaling has also been implicated in STAT3-dependent negative regulation of murine mast cells and activated macrophages (9, 13).
Cytokines have been shown to be critically involved in both protective and pathogenic antimicrobial immune responses. As an imbalance in cytokine responses may result in persistent infections or destructive systemic inflammatory response leading to multiorgan failure and death (1), a detailed understanding of local cytokine function during infections is of crucial importance for therapy of sepsis. However, the factors that determine the immune response during sepsis are still incompletely understood. Here, we demonstrate a crucial role of IL-27 in innate immunity and experimental septic peritonitis.
| RESULTS AND DISCUSSION |
|---|
|
|
|---|
|
50% of the EBI3/ mice survived for more than 2 wk. In addition, i.p injection of 4 x 108 live Escherichia coli led to high lethality in wild-type mice, whereas all EBI3/ mice survived (Fig. 2 B). These data suggested that IL-27 EBI/ mice are more resistant to lethality induced by microbial infections.
|
Increased early leukocyte influx and bacterial clearance in IL-27 EBI3/ mice
In an initial attempt to explore the functional role of IL-27 in septic peritonitis, we next examined whether decreased mortality in EBI3/ mice is associated with changes in cell numbers of the peritoneal cavity. Therefore, we assessed the leukocyte influx into the peritoneum after CLP and found that the granulocyte infiltration at 4 h was significantly augmented in IL-27deficient mice as compared with wild-type mice (Fig. 3 A).
Similar results were obtained 4 h after i.p. challenge of wild-type and knockout mice with 1.5 ml of 3% thioglycollate (Fig. 3 A).
|
IL-27 down-regulates protective innate immune responses of myeloid cells
It has been recently shown that a variety of immune cells besides T and NK cells may express both IL-27 receptor chains (5). We thus evaluated whether murine macrophages and polymorphonuclear neutrophils express WSX-1. RT-PCR and Western blot analysis revealed that both cell types express WSX-1 (Fig. S1, available at http://www.jem.org/cgi/content/full/jem.20060471/DC1) and thus can potentially respond to IL-27 stimulation.
Because the findings described above indicated that the improved survival of EBI3/ mice was related to a more effective bacterial clearance and local control of infection, we next compared the bactericidal activity of leukocytes between EBI3/ and EBI3+/+ mice by analyzing reactive oxygen intermediates (ROI). Mice were injected with 1.5 ml of 3% thioglycollate for 4 and 24 h to generate an inflammatory stimulus, and their potency to produce ROI was determined using flow cytometry. Interestingly, granulocytes from EBI3/ mice displayed a markedly enhanced ability to produce ROI as compared with EBI3+/+ mice, suggesting that IL-27 negatively regulates the biological functions of granulocytes (Fig. 4 A).
To further verify the latter hypothesis, we next isolated elicited leukocytes from wild-type C57BL/6 mice and stimulated them for 12 h with LPS or LPS plus rIL-27. As shown in Fig. 4 B, rIL-27 down-regulated LPS-induced activation and ROI production of both granulocytes and monocytes/macrophages. However, rIL-27 alone had no effect on ROI production, suggesting that this cytokine controls inducible ROI production upon TLR ligation. In a subsequent series of studies, we determined systemic cytokine levels using bead multiplexing technology. Although no differences in levels of IL-10, TNF, and IFN-
were noted, levels of IL-1 and IL-6 were significantly reduced in EBI3/ mice as compared with wild-type mice at 20 h after CLP, suggesting that the enhanced control of infection in EBI3-deficient mice results in lower production of some proinflammatory cytokines as compared with wild-type mice (Fig. 4 C).
|
|
The regulation of neutrophil functions during septic peritonitis is still incompletely understood. However, C5a/C5aR and TREM signaling have been recently identified as important modulators of the biological function of these cells (1922). Here, we found that IL-27 subunits were rapidly produced by both macrophages and neutrophils during septic peritonitis. This rapid production is presumably due to augmented EBI3 and p28 gene transcription, as both promoters contain TLR-responsive NF-
B binding elements (8).
Our data suggest a novel key role of IL-27 in regulating innate immunity and neutrophil function during septic peritonitis. Specifically, IL-27 modulates neutrophil influx/activation by an as yet unknown mechanism that presumably involves modulation of chemokines. Consistently, we recently found that IL-27 suppresses production of various chemokines in myeloid cells such as RANTES and I-TAC that control migration of immune cells (unpublished data). Furthermore, we identified IL-27 as a key negative regulator of oxidative burst by neutrophils. The clinical relevance of these observations was underlined in two models of experimental peritonitis. First, we observed that EBI3/ mice were protected from experimental septic peritonitis, and injection of recombinant IL-27 prevented such protection. Second, we found that EBI3/ mice have significantly reduced mortality upon i.p. injection of live E. coli. In both models, IL-27 EBI3/ mice had significantly reduced numbers of bacteria in the peritoneum and blood associated with an increased oxidative burst capacity of neutrophils. The fact that neutrophils produce a cytokine such as IL-27 that inhibits their influx/activation may represent an autoregulatory loop to limit neutrophil responses, or, more likely, may indicate that IL-27 has additional positive functional roles that remain to be elucidated.
Collectively, our data suggest a major role of IL-27 in modulating influx and oxidative burst of granulocytes and elimination of bacteria during peritonitis. Thus, early IL-27 production by myeloid cells may exert a negative feedback mechanism that limits protective innate immune responses in peritonitis. The therapeutic implication of these observations was finally highlighted by the finding that blockade of IL-27 function using a newly designed sIL-27R fusion protein suppressed experimental septic peritonitis and reduced mortality in vivo. Thus, our data provide novel insights into the cytokine-driven regulation of neutrophil function during sepsis. Furthermore, blockade of IL-27 function by sIL-27R could be a novel treatment modality for patients with septic peritonitis.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Measurement of cytokines.
For measurement of cytokines in peritoneal lavage fluid or serum/plasma, we used the mouse FlowCytomix kit (Bender Medsystems) according to the manufacturer's instructions using a FACSCalibur System (Becton Dickinson). IL-27 levels were determined by sandwich ELISA (R&D Systems).
Determination of CFUs.
Serial dilutions of peripheral blood or peritoneal lavage fluid of CLP-treated or E. coliinjected mice were plated on Caso blood agar plates (Heipha) at 37°C. CFUs were determined after 24 h.
Determination of leukocyte oxidative burst activity.
Intracellular respiratory burst activity was measured separately in monocytes and neutrophils using the Phagoburst kit (Orpegen) according to the manufacturer's instructions. In brief, 100 µl of heparinized peripheral blood was mixed with 20 µl of a substrate solution containing nonfluorescent dihydrorhodamine 123 (DHR) and incubated for 10 min at 37°C. Oxidation of DHR to the green fluorescent rhodamine 123 was used as an indicator of respiratory burst. The percentage of ROI-producing cells was counted in a flow cytometer (FACSCalibur; Becton Dickinson). To discriminate monocytes and granulocytes, gates were set by a linear FCS/SSC analysis.
Isolation of resident macrophages and elicited neutrophils.
For isolation of resident macrophages, mice were injected with 5 ml PBS. Macrophages were isolated from peritoneal lavage by plastic adherence. For isolation of granulocytes, mice were injected i.p. with 1.5 ml sterile thioglycollate (3%). Elicited cells were harvested 4 h later by peritoneal lavage with 5 ml of cold PBS. In some experiments, neutrophils were further purified from peritoneal lavage by magnetic cell sorting. In brief, cells were labeled with an FITC-conjugated anti-neutrophil antibody (Caltag) and sorted to a purity of >95% with the FITC multisort kit (Miltenyi Biotec).
Quantitative analysis of gene expression.
Total cellular RNA was extracted from cells and organs with RNeasy columns (QIAGEN), including DNase I digestion. Quantitative real-time PCR analysis for IL-27 EBI3 and p28, IL-12 p35, IL-23 p19, IL-12/IL-23 p40, and HPRT was performed using specific Quantitect Primer/Probe assays (QIAGEN).
scIL-27 and sIL-27R.
For construction of bioactive murine IL-27, the cDNAs encoding for EBI3 and p28 were cloned from LPS-stimulated splenocytes by reverse transcriptase PCR. For cloning of single-chain IL-27 (scIL-27), fragments encoding the EBI3 part, followed by a Val4Gly4Pro2 linker and the mature coding sequence of p28, were generated by PCR and cloned into the p3XFlag expression vector (Sigma-Aldrich). To ensure efficient secretion, the EBI3 leader sequence was replaced by the signal peptide of IgG
.
The cDNA coding for a soluble WSX fusion protein was generated by ligation of the extracellular portion of WSX-1 to the Fc part of IgG2a. The extracellular part of WSX-1 was cloned into pCDNA3.1TOPO expression vector by PCR using PfuUltra (Stratagene) and a primer introducing a factor Xa cleaving site followed by an XhoI site (pcDNA3.1-sWSX). The Fc part of IgG2a was amplified from cDNA of the OKT3 hybridoma and cloned into the XhoI-cut pcDNA3.1-sWSX vector. For protein expression, CHO cells were transfected with 5 µg of linearized plasmid DNA and stable transfectants were isolated by selection with 1 mg/ml G418. Culture supernatants of stable transfectants were harvested, and the fusion protein was purified from the supernatant with Fastflow protein G columns (GE Healthcare).
Statistical analysis.
Data are expressed as mean values ± standard deviations. Statistical analysis was performed using the unpaired Student's t test or with a log rank test for survival analysis (*, P < 0.05; **, P < 0.01; ***, P < 0.001).
Online supplemental material.
Fig. S1 shows the expression of the IL-27 receptor on mouse-resident peritoneal macrophages and elicited neutrophils. Fig. S2 shows the specific down-regulation of IL-27induced proliferation of T cells by sIL-27R. Fig. S3 shows a comparison of HMGB1 expression in septic EBI3/ and EBI3+/+ mice. Figs. S1S3 are available at http://www.jem.org/cgi/content/full/jem.20060471/DC1.
| Acknowledgments |
|---|
The research of M.F. Neurath was supported by the Deutsche Forschungsgemeinschaft (DFG) and the SFB 490 of the DFG.
The authors have no conflicting financial interests.
Submitted: 28 February 2006
Accepted: 6 July 2006
| REFERENCES |
|---|
|
|
|---|
1 Cohen, J. 2002. The immunopathogenesis of sepsis. Nature. 420:885891.[CrossRef][Medline]
2 Hotchkiss, R.S., and I.E. Karl. 2003. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348:138150.
3 Pflanz, S., J.C. Timans, J. Cheung, R. Rosales, H. Kanzler, J. Gilbert, L. Hibbert, T. Churakova, M. Travis, E. Vaisberg, et al. 2002. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity. 16:779790.[CrossRef][Medline]
4 Devergne, O., M. Hummel, H. Koeppen, M.M. Le Beau, E.C. Nathanson, E. Kieff, and M. Birkenbach. 1996. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J. Virol. 70:11431153.[Abstract]
5 Pflanz, S., L. Hibbert, J. Mattson, R. Rosales, E. Vaisberg, J.F. Bazan, J.H. Phillips, T.K. McClanahan, R. de Waal Malefyt, and R.A. Kastelein. 2004. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 172:22252231.
6 Neurath, M.F., S. Finotto, and L.H. Glimcher. 2002. The role of Th1/Th2 polarization in mucosal immunity. Nat. Med. 8:567573.[CrossRef][Medline]
7 Kamiya, S., T. Owaki, N. Morishima, F. Fukai, J. Mizuguchi, and T. Yoshimoto. 2004. An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells. J. Immunol. 173:38713877.
8 Wirtz, S., C. Becker, M.C. Fantini, E.E. Nieuwenhuis, I. Tubbe, P.R. Galle, H.J. Schild, M. Birkenbach, R.S. Blumberg, and M.F. Neurath. 2005. EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation. J. Immunol. 174:28142824.
9 Artis, D., A. Villarino, M. Silverman, W. He, E.M. Thornton, S. Mu, S. Summer, T.M. Covey, E. Huang, H. Yoshida, et al. 2004. The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity. J. Immunol. 173:56265634.
10 Villarino, A., L. Hibbert, L. Lieberman, E. Wilson, T. Mak, H. Yoshida, R.A. Kastelein, C. Saris, and C.A. Hunter. 2003. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity. 19:645655.[CrossRef][Medline]
11 Villarino, A.V., J.S. Stumhofer, C.J. Saris, R.A. Kastelein, F.J. de Sauvage, and C.A. Hunter. 2006. IL-27 limits IL-2 production during Th1 differentiation. J. Immunol. 176:237247.
12 Nieuwenhuis, E.E., M.F. Neurath, N. Corazza, H. Iijima, J. Trgovcich, S. Wirtz, J. Glickman, D. Bailey, M. Yoshida, P.R. Galle, et al. 2002. Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice. Proc. Natl. Acad. Sci. USA. 99:1695116956.
13 Holscher, C., A. Holscher, D. Ruckerl, T. Yoshimoto, H. Yoshida, T. Mak, C. Saris, and S. Ehlers. 2005. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J. Immunol. 174:35343544.
14 Scheller, J., B. Schuster, C. Holscher, T. Yoshimoto, and S. Rose-John. 2005. No inhibition of IL-27 signaling by soluble gp130. Biochem. Biophys. Res. Commun. 326:724728.[CrossRef][Medline]
15 Aderem, A., and R.J. Ulevitch. 2000. Toll-like receptors in the induction of the innate immune response. Nature. 406:782787.[CrossRef][Medline]
16 Thoma-Uszynski, S., S. Stenger, O. Takeuchi, M.T. Ochoa, M. Engele, P.A. Sieling, P.F. Barnes, M. Rollinghoff, P.L. Bolcskei, M. Wagner, et al. 2001. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science. 291:15441547.
17 Medzhitov, R., and C. Janeway Jr. 2000. Innate immunity. N. Engl. J. Med. 343:338344.
18 Rosas, L.E., A.A. Satoskar, K.M. Roth, T.L. Keiser, J. Barbi, C. Hunter, F.J. de Sauvage, and A.R. Satoskar. 2006. Interleukin-27R (WSX-1/ T-cell cytokine receptor) gene-deficient mice display enhanced resistance to Leishmania donovani infection but develop severe liver immunopathology. Am. J. Pathol. 168:158169.
19 Gibot, S., M.N. Kolopp-Sarda, M.C. Bene, P.E. Bollaert, A. Lozniewski, F. Mory, B. Levy, and G.C. Faure. 2004. A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J. Exp. Med. 200:14191426.
20 Riedemann, N.C., R.F. Guo, K.D. Bernacki, J.S. Reuben, I.J. Laudes, T.A. Neff, H. Gao, C. Speyer, V.J. Sarma, F.S. Zetoune, and P.A. Ward. 2003. Regulation by C5a of neutrophil activation during sepsis. Immunity. 19:193202.[CrossRef][Medline]
21 Guo, R.F., and P.A. Ward. 2005. Role of C5a in inflammatory responses. Annu. Rev. Immunol. 23:821852.[CrossRef][Medline]
22 Colonna, M. 2003. TREMs in the immune system and beyond. Nat. Rev. Immunol. 3:445453.[CrossRef][Medline]
Related Article
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| TABLE OF CONTENTS |
|